首页 | 本学科首页   官方微博 | 高级检索  
检索        

安奇治疗小儿呼吸道感染的临床和药物经济学分析
引用本文:周仁江,赵平,罗雁红,许峰.安奇治疗小儿呼吸道感染的临床和药物经济学分析[J].儿科药学杂志,2002,8(2):24-25.
作者姓名:周仁江  赵平  罗雁红  许峰
作者单位:1. 西南铝业集团职,工医院,401326
2. 重庆医科大学附属儿童医院,400014
摘    要:目的 :探讨安奇静脉注射和静脉口服序贯疗法治疗小儿呼吸道感染的疗效和成本效果分析。方法 :将 40例临床诊断为呼吸道感染的病儿 ,随机分为安奇静脉注射组和安奇静脉 -口服序贯疗法组 ,观察临床疗效并作成本 -效果分析。结果 :两组临床有效率均为 85 % ,在药物经济学上安奇静脉 -口服序贯疗法优于安奇静脉注射组。结论 :安奇抗菌谱广、安全 ,静脉 -口服序贯疗法治疗小儿呼吸道感染值得临床推广。

关 键 词:阿莫西林/克拉维酸  呼吸道感染  药物经济学
文章编号:1009-6884(2002)02-0024-02
修稿时间:2002年3月18日

Clinical and pharmaco-economic analysis of Anqi therapy in children with respiratory infection
ZHOU Renjiang ,ZHAO Ping ,LUO Yanhong ,XU Feng.Clinical and pharmaco-economic analysis of Anqi therapy in children with respiratory infection[J].Journal of Pediatric Pharmacy,2002,8(2):24-25.
Authors:ZHOU Renjiang  ZHAO Ping  LUO Yanhong  XU Feng
Institution:1.Worker's Hospital of Southwestern Aluminium Process Factory 401326;2.Children's Hospital Chongqing University of Medical Sciences 400014
Abstract:Objective:To investigate the clinical effect of Anqi(amoxicillin/clavulanic acid)and to analyze the cost effect of intravenous infusion(iv)Anqi only and iv oral sequence administration of Anqi in children with respiratory disease Method:40 Patients were randomized into two groups,iv Anqi group or iv Anqi for 3 days followed by oral Anqi for 3 days,iv oral sequence Anqi group Clinical effect and cost-effect analysis were carried out Result:Clinical effective rate was 85 per cent inboth groups The cost-effect ratio of iv oral sequence Anqi group is lower than that of iv Anqi group from pharmaco-economic point of view Conclusion:Anqi is a safe antibiotic drug that covers a wide bacterial spectrum Intravenous infusion followed by oral administration of Anqi therapy is recommended
Keywords:Amoxicillin/Clavulanic acid  Respiratory infection  Pharmaco-economic
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号